Online tech learner logo
Online Tech Learner
  • Please enable News ticker from the theme option Panel to display Post

Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 – Bausch Health Companies Inc.

Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 – Bausch Health Companies Inc.

[ad_1]

LAVAL, Quebec, Feb. 1, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) will release fourth-
quarter and full-year 2023 financial results on Thursday, Feb. 22, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

A replay of the conference call will be available on the investor relations website.

To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

 

###

Investor Contact:
ir@bauschhealth.com
(877) 281-6642 (toll free)

Media Contact:
Kevin Wiggins
corporate.communications@bauschhealth.com
(908) 541-3785

[ad_2]

Source link

administrator

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *